Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
INSULIN ASPART
Insulin aspart Sanofi
Diabetes Mellitus, Type 1 and 2
PDY15084NANCT03916601Publication's Reference
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
ACT12374NAEudraCT: 2011-002090-36Summary Results
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 1
BDR10880NASummary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 1
BDR11038NASummary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 1
BDR11578NASummary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC12404Lixi-Lan-ONCT02058147Summary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC12405Lixi-Lan-LNCT02058160Summary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC13794LixiLan-GNCT02787551Tabulated Results
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC14112LIXILAN JP-O1NCT02749890Publication's Reference
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC14113LIXILAN JP-LNCT02752412Publication's Reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted